Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frederick Hiller Ii

TitleProfessor Emeritus
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Med, College of Medicine
DivisionInternal Med Pulmonary
Address SHOR 3S14
4301 W Markham St.
Mail Slot # 555
Little Rock AR 72205
Phone501-686-5525
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    LABA/ICS     (HILLER II, FREDERICK C)Feb 8, 2012
    Forest Research Institute
    A 52-week, Double-Blind, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Effect of Roflumilast 500 µg on Exacerbation Rate in Subj
    Role: Principal Investigator
    BY217 M2-125     (HILLER II, FREDERICK C)Jan 4, 2007 - Jan 4, 2009
    Altana Pharma
    Effect of roflumilast on exacerbation rate in patients with COPD. A 52 week, double-blind study with 500 mcg roflumilast once daily versus placebo.
    Role: Principal Investigator
    BY217M2     (HILLER II, FREDERICK C)Jan 4, 2007 - Jan 4, 2009
    Altana Pharma
    Effect of roflumilast on exacerbation rate in patients with COPD. A 52 week, double-blind study with 500 mcg roflumilast once daily versus placebo.
    Role: Principal Investigator
    COV     (HILLER II, FREDERICK C)Nov 30, 2006 - Dec 1, 2007
    Almirall Prodesfarma, S.A.
    a comparative study of LAS 34273 versus placebo in the treatment of stable, moderate to severe COPD, also known as ACCLAIM II
    Role: Principal Investigator
    COV-2731     (HILLER II, FREDERICK C)Nov 30, 2006 - Dec 1, 2007
    Almirall Prodesfarma, S.A.
    a comparative study of LAS 34273 versus placebo in the treatment of stable, moderate to severe COPD, also known as ACCLAIM II
    Role: Principal Investigator
    ARIA 28648 CTA     (HILLER II, FREDERICK C)Jan 10, 2005 - Mar 1, 2005
    PPD Development, LP
    Protocol 3000-0409: Phase III, Randomized, Open-Label, Study of Aquavan Injection vs Midazolam HCL for Sedation in Patients Undergoing Flexible Bronch
    Role: Principal Investigator
    ARIA28648CTA     (HILLER II, FREDERICK C)Jan 10, 2005 - Mar 1, 2005
    PPD Development, LP
    Protocol 3000-0409: Phase III, Randomized, Open-Label, Study of Aquavan Injection vs Midazolam HCL for Sedation in Patients Undergoing Flexible Bronch
    Role: Principal Investigator
    NA17098     (HILLER II, FREDERICK C)Jun 1, 2003 - Jun 1, 2004
    Hoffmann-La Roche, Inc.
    Protocol No. NA17098, “A Multi-Center, Randomized, Double-Blind, Placebo, Controlled Phase 2a Dose-Response Study of the Safety and Tolerability of Tw
    Role: Principal Investigator
    CFOR258D     (HILLER II, FREDERICK C)May 1, 2002 - Oct 1, 2004
    NOVARTIS Pharmaceuticals Corporation
    A randomized, multicenter, placebo-controlled parallel group study of four months duration per subject to evaluate the safety and efficacy of treatmen
    Role: Principal Investigator
    CFOR258D Amend. 1     (HILLER II, FREDERICK C)May 1, 2002 - Oct 1, 2004
    NOVARTIS Pharmaceuticals Corporation
    A randomized, multicenter, placebo-controlled parallel group study of four months duration per subject to evaluate the safety and efficacy of treatmen
    Role: Principal Investigator
    CFOR258D Amend. 2     (HILLER II, FREDERICK C)May 1, 2002 - Oct 1, 2004
    NOVARTIS Pharmaceuticals Corporation
    A randomized, multicenter, placebo-controlled parallel group study of four months duration per subject to evaluate the safety and efficacy of treatmen
    Role: Principal Investigator
    CFOR258DAmend.1     (HILLER II, FREDERICK C)May 1, 2002 - Oct 1, 2004
    NOVARTIS Pharmaceuticals Corporation
    A randomized, multicenter, placebo-controlled parallel group study of four months duration per subject to evaluate the safety and efficacy of treatmen
    Role: Principal Investigator
    CFOR258DAmend.2     (HILLER II, FREDERICK)May 1, 2002 - Oct 1, 2004
    NOVARTIS Pharmaceuticals Corporation
    A randomized, multicenter, placebo-controlled parallel group study of four months duration per subject to evaluate the safety and efficacy of treatmen
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. M.F.Siddiqui.MD MPH, S. Badireddi MD, E.J. Anaissie MD, B. Barlogie MD PhD, F.C. Hiller MD. Effect Of High Dose Chemotherapy And Autologous Stem Cell Transplantation On Obstructive Lung Disease In Multiple Myeloma. 2012.
    2. Hiller ii F. Cystic Fibrosis Masquerading as Asthma and Bronchitis in Young Adults. Pediatric Asthma, Allergy and Immunology. 2003.
    3. Hiller FC, Alderfer V, Goldman M. Long-term use of Viozan (sibenadet HCl) in patients with chronic obstructive pulmonary disease: results of a 1-year study. Respir Med. 2003; 97 Suppl A:S45 - S52.
    4. Goodwin TE, Zhou X, Haile PA, Breen P, Anderson PJ, Hiller ii F, Compadre CM. Synthesis of 13C,D3-Salmeterol. Journal of Labelled Compounds and Radiopharmaceuticals. 2000; (43):65-75.
    5. Olsen KM, Hiller FC, Ackerman BH, Crisp-Landwehr K, San Pedro GS. Effect of single intravenous doses of Histamin2-receptor antagonists on volume and pH of gastric-acid secretions in critically ill patients. Current Ther. Res. 1995; (56):756-768.
    6. Dietz T, Talley JD, Hiller ii F, Golper TA. Expanding indications for thrombolytic therapy. J Ark Med Soc. 1995; (92):240-245.
    7. Hiller ii F, Olsen KM, Gann LP, Erbland ML. Nicotine Blood Levels Measured After Smoking Cigarettes Designed to Release Nicotine By Heat Vaporization Instead of Burning. S.T.P. Pharma Sciences. 1994; (4):77-81.
    8. Burch SG, Gann LP, Olsen KM, Anderson PJ, Hiller FC, Erbland ML. Effect of pH on Nicotine Absorption and Side Effects Produced By Aerosolized Nicotine. J of Aerosol Med. 1993; 6(1):45-52.
    9. Herrmann DR, Olsen KM, Hiller FC. Nicotine absorption after pulmonary instillation. J Pharm Sci. 1992; 81(11):1055 - 1058.
    10. Hiller ii F. Health implications of hygroscopic particle growth in the human respiratory tract. J of Aerosol Med. 1991; (4):1-23.
    11. Thomas EE, Smith JB, Hiller FC. Nutrition and exercise for weight control as a treatment for the obese with obstructive sleep apnea; patient education. J Polysomnographic Technol. 1991; (December):11-16.
    12. Scrima L, Hartman PG, Johnson FH, Thomas EE, Hiller FC. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep. 1990; 13(6):479 - 490.
    13. Hackler JC, Hiller FC. Family consent to orders not resuscitate. Reconsidering hospital policy. JAMA. 1990; 264(10):1281 - 1283.
    14. Olsen KM, Hiller FC, Ackerman BH, McCabe BJ. Effect of enteral feedings on oral phenytoin absorption. Nutr Clin Pract. 1989; 4(5):176 - 178.
    15. Scrima L, Hartman PG, Johnson FH, Hiller FC. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures. Biol Psychiatry. 1989; 26(4):331 - 343.
    16. Scrima L, Hartman PG, Hiller FC. Effect of three alcohol doses on breathing during sleep in 30-49 year old nonobese snorers and nonsnorers. Alcohol Clin Exp Res. 1989; 13(3):420 - 427.
    17. Wetmore SJ, Scrima L, Hiller FC. Sleep apnea in epistaxis patients treated with nasal packs. Otolaryngol Head Neck Surg. 1988; 98(6):596 - 599.
    18. Hiller ii F. Occupational Lung Disease. Annual Review of Pulmonary and Critical Care Medicine. 1988; 87-98.
    19. Olsen KM, Hiller FC. Management of tetanus. Clin Pharm. 1987; 6(7):570 - 574.
    20. Hiller ii F. Occupational Lung Disease. Annual Review of Pulmonary and Critical Care Medicine. 1987; 185-196.
    21. Tsai MS, Hiller FC. Flow volume loops in airway obstruction: analysis of six typical examples with obstructions at different locations. Gaoxiong Yi Xue Ke Xue Za Zhi. 1986; 2(9):581 - 589.
    22. Wetmore SJ, Scrima LW, Snyderman NL, Hiller FC. Obstructive sleep apnea: current therapy. J Ark Med Soc. 1986; 83(4):171 - 173.
    23. Wetmore SJ, Scrima L, Snyderman NL, Hiller FC. Postoperative evaluation of sleep apnea after uvulopalatopharyngoplasty. Laryngoscope. 1986; 96(7):738 - 741.
    24. Hiller ii F. Air Pollution. Pulmonary Disease Reviews. 1986; 6.
    25. Hiller ii F. Occupational Lung Disease. Annual Review of Pulmonary and Critical Care Medicine. 1986; 105-113.
    26. Hiller ii F. Occupational Lung Disease. Pulmonary Disease Reviews. 1986; 6:149-166.
    27. Balk RA, Hiller FC, Lucas EA, Scrima L, Wilson FJ, Wooten V. Sleep apnea and the Arnold-Chiari malformation. Am Rev Respir Dis. 1985; 132(4):929 - 930.
    28. Hiller FC. Review of air pollution control: approach in the United States and selected European countries. Gaoxiong Yi Xue Ke Xue Za Zhi. 1985; 1(4):258 - 266.
    29. Wilson FJ, Hiller FC, Wilson JD, Bone RC. Quantitative deposition of ultrafine stable particles in the human respiratory tract. J Appl Physiol. 1985; 58(1):223 - 229.
    30. Hiller FC. Deposition of sidestream cigarette smoke in the human respiratory tract. Prev Med. 1984; 13(6):602 - 607.
    31. Hiller FC, Wilson FJ, Mazumder MK, Wilson JD, Bone RC. Concentration and particle size distribution in smoke from marijuana cigarettes with different delta 9-tetrahydrocannabinol content. Fundam Appl Toxicol. 1984; 4(3 Pt 1):451 - 454.
    32. Webb RT, Beaton JN, Wilson FJ, Hiller FC. Shifting granuloma: a sign of lobar collapse. Chest. 1984; 85(4):559 - 560.
    33. Popovich K.L., C. Hiller, A. Hough, Norris J.S., Cornett L.E. Characterization of B-adrenergic receptor in porcine trachealis muscle. Am J Physiology. 1984; (247):C342-C349.
    34. Hiller ii F. Occupational Lung Disease. Pulmonary Disease Reviews. 1984; 5:481-499.
    35. Popovich KJ, Hiller C, Hough A, Norris JS, Cornett LE. Characterization of B-adrenergic receptor in porcine trachealis muscle. Am J Physiol Cell. 1984; 342-349.
    36. Hiller ii F. Air Pollution. Pulmonary Disease Reviews. 1984; 457-579.
    37. McCusker K, Hiller FC, Wilson JD, Mazumder MK, Bone R. Aerodynamic sizing of tobacco smoke particulate from commercial cigarettes. Arch Environ Health. 1983; 38(4):215 - 218.
    38. Hiller FC, Wilson FJ. Evaluation and management of acute asthma. Med Clin North Am. 1983; 67(3):669 - 684.
    39. Hiller ii F. Air Pollution. Pulmonary Disease Reviews. 1983; 4:445-461.
    40. Hiller F, Wilson FJ, Bone RC (eds). Pulmonary Disease: Focus on Clinical Diagnosis. Medical Examination Publishing Company, Garden City, NY. 1983.
    41. Jacobs ER, Soulsby ME, Bone RC, Wilson FJ, Hiller FC. Ibuprofen in canine endotoxin shock. J Clin Invest. 1982; 70(3):536 - 541.
    42. Wewers MD, Hiller FC, Wilson FJ, Bone RC. Haemophilus influenzae infection of an existing lung cyst. South Med J. 1982; 75(6):736 - 737.
    43. Hiller FC, McCusker KT, Mazumder MK, Wilson JD, Bone RC. Deposition of sidestream cigarette smoke in the human respiratory tract. Am Rev Respir Dis. 1982; 125(4):406 - 408.
    44. Hiller ii F. Occupational Lung Disease. Pulmonary Disease Reviews. 1982; 3:601-618.
    45. Hiller ii F. Air Pollution. Pulmonary Disease Reviews. 1982; 3:585-600.
    46. McCusker KT, Hiller ii F, Wilson JD, McLeod P, Sims R, Bone RC. Dilution of cigarette smoke for real time aerodynamic sizing with SPART analyzer. J Aerosol Sci. 1982; (13):103-110.
    47. Hiller ii F, Mazumder MK, Wilson JD, McLeod PC, Bone RC. Human respiratory tract deposition using multimodal aerosols. J Aerosol Science. 1982; (13):337-343.
    48. Hiller FC, Mazumder MK, Wilson JD, Renninger RG, Bone RC. Physical properties of therapeutic aerosols. Chest. 1981; 80(6 Suppl):901 - 903.
    49. McCusker KT, Hiller FC, Mazumder MK, Bone RC. Effects of contemporary filters on cigarette smoke. Chest. 1981; 80(1 Suppl):80 - 81.
    50. Hiller ii F, Bone RC. Air Pollution. Pulmonary Disease Reviews. 1981; 2:249-270.
    51. McCusker KT, Hiller ii F, Bone RC. Cigarette Smoking. Pulmonary Disease Reviews. 1981; 2:119-128.
    52. Hiller ii F, Bone RC. Occupational lung disease. Pulmonary Disease Reviews. 1981; 2:271-294.
    53. Wilson FJ, Bone RC, Hiller FC. Fiberoptic bronchoscopy. Ann Rev Allergy. 1981; 25-51.
    54. Renniger RG, Hiller ii F, Bone RC. The evaporation and growth of droplets having more than one volatile constituent. J Aerosol Sci. 1981; 12::501-515.
    55. Hiller FC, Mazumder MK, Wilson JD, Bone RC. Aerodynamic size distribution, hygroscopicity and deposition estimation of beclomethasone dipropionate aerosol. J Pharm Pharmacol. 1980; 32(9):605 - 609.
    56. Hargis JL, Bone RC, Stewart J, Rector N, Hiller FC. Intracavitary amphotereicin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med. 1980; 68(3):389 - 394.
    57. Smith G, Hiller C, Mazumder M, Bone R. Aerodynamic size distribution of cromolyn sodium at ambient and airway humidity. Am Rev Respir Dis. 1980; 121(3):513 - 517.
    58. Hiller FC, Mazumder MK, Wilson JD, Bone RC. Effect of low and high relative humidity on metered-dose bronchodilator solution and powder aerosols. J Pharm Sci. 1980; 69(3):334 - 337.
    59. Hiller FC, Lucas EA, Phillips JR, Wewers MD. Medical grand rounds: sleep apnea syndrome. J Ark Med Soc. 1980; 76(10):391 - 398.
    60. Hiller FC, Mazumder MK, Smith GM, Bone RC. Physical properties, hygroscopicity and estimated pulmonary retention of various therapeutic aerosols. Chest. 1980; 77(2 Suppl):318 - 321.
    61. Hiller FC, Mazumbder MK, Smith GM, Bone RC. Aerodynamic size distribution, hygroscopicity, and estimated pulmonary retention of therapeutic aerosols. Chest. 1980; 77S::318S-321S.
    62. Hiller ii F, Bone RC, Wilson FJ. Prevention of postoperative pulmonary complications. Respir Ther. 1980; 10::87-95.
    63. Bone R, Said S, Hiller C, Wilson F. Vasoactive Intestinal Polypeptide in Endtoxin Shock. 1980; (suppl.).
    64. Hiller FC, Bone RC. Occupational lung disease. Pulmonary Disease Reviews. 1980; 1:259.
    65. Hiller FC, Bone RC. Air Pollution. Pulmonary Disease Reviews. 1980; 1:247.
    66. Hiller FC, Bone RC. Aerosols as therapeutic and research tools. Pulmonary Disease Reviews. 1980; 1:277.
    67. McCusker K, Hiller C, Mazumder M, Bone R. Physical Properties of Smoke from Cigarettes Compared to Pipes. 1980; 530.
    68. Smith G, Hiller C, Renninger R, Mazumder M, Bone R. Theoretical and Experimental Studies of Propylene Glycol Aerosols. 1980; 842A.
    69. Hargis, JL, Bone RC, Hiller FC, Wilson FJ. Pulmonary blastomycosis diagnosed by thoracentesis. Chest. 1980; 77::455.
    70. McCusker B, Bone RC, Hiller ii F, Wilson FJ. VD/VT and Compliance on Non-Invasive Measures of Cardiac Output During Administration of PEEP in Acute Respiratory Failure. 1980; (suppl.).
    71. McCusker K, Hiller C, Mazumder M, Bone R. Characterization of Sidestream Smoke from Low Tar Cigarettes and Cigars. 1980; 841A.
    72. McCusker K, Hiller C, Mazumder M, Bone R. Contemporary Filters and their Effects on Cigarette Smoke. 1980; 530.
    73. Hiller C, Mazumder M, Wilson D, Bone R. Quantitative Simultaneous Measurements of Deposition of Aerosols of Different Sizes in the Human. 1980; 840A.
    74. Stonesifer LD, Bone RC, Hiller FC. Thrombotic thrombocytopenic purpura in carbon monoxide poisoning. Report of a case. Arch Intern Med. 1980; 140(1):104 - 105.
    75. Hiller C, Mazumder M, Wilson D, McCusker K, Warren R, Bone R. Characteristics of Aerosols Produced by Hand-Held Nebulizers. 1980; 148.
    76. Wilson FJ, Bone RC, Hiller FC. Method for sampling airway gas. Crit Care Med. 1979; 7(7):307 - 309.
    77. Bone RC, Hiller FC, Ebert RV, Phillips JR, McCusker KT. Tobacco and the lung. J Ark Med Soc. 1979; 75(12):458 - 463.
    78. Mazumder MK, Ware RE, Wilson JD, Renninger RG, Hiller FC, McLeod PC, Raible RW, Testerman MK. SPART Analyzer: It's application to aerodynamic size distribution measurement. Aerosol Sci. 1979; 10::561-569.
    79. Hiller C, Mazumder M, Wilson D, Bone R. Growth of Metered-Dose-Bronchodilator Aerosols at High Humidity. 1979; 128.
    80. Hiller C, Bone R, Wilson F. Comparison of Tissue and Mixed Venous Oxygen Tension in Endotoxin Shock. 1979; 127.
    81. Hiller C, Bone R, Wilson F. Brain Subcutaneous Tissue and Mixed Venous Oxygen Tensions and Indicators of Cardiopulmonary Performances in Endtoxin Shock. 1979; 354.
    82. Hargis JL, Hiller FC, Bone RC. Migratory pulmonary infiltrates secondary to aspirated foreign body. JAMA. 1978; 240(22):2469 - .
    83. Hiller C, Mazumder M, Wilson D, Bone R. Aerodynamic size distribution of metered-dose bronchodilator aerosols. Am Rev Respir Dis. 1978; 118(2):311 - 317.
    84. Sobonya RE, Hiller FC, Pingleton W, Watanabe I. Fatal measles (rubeola) pneumonia in adults. Arch Pathol Lab Med. 1978; 102(7):366 - 371.
    85. Bone RC, Hiller C. Modern treatment of bronchial asthma. JACEP. 1978; 7(7):269 - 275.
    86. Hiller C, Mazumder M, Wilson D, Bone R. Sodium Cromolyn Aerosol: Humidity Particle Size and Human Retention. 1978; 448A.
    87. Hiller C, Mazumder M, Wilson D, Bone R. Cromolyn Aerosol: Increase in Particle Size in High Humidity. 1978; 340.
    88. Hiller C, Mazumder M, Wilson D, Bone RC. Aerodynamic Size Distribution of and Cromolyn Aerosols. 1978; 37A.
    89. Hiller C, Bone R. Assessment of Correlation Between Tissue Oxygen and Mixed Venous Oxygen. 1978; 126.
    90. Murphy EM, Bone RC, Hiller FC, Diederich DA, Ruth WE. The oxyhemoglobin dissociation curve in type A and type B COPD. Lung. 1978; 154(4):299 - 305.
    91. Hiller C, Bone R. Correlation of tissue oxygen and mixed venous oxygen during hemmorrhage and hypoxia. 1978; 448A.
    92. Hiller C, Lerner S, Varnum R, Bone R, Pingelton W, Kerby G, Ruth W. Foreign body removal with the flexible fiberoptic bronchoscope. Endoscopy. 1977; 9(4):216 - 222.
    93. Pingleton WW, Hiller FC, Bone RC, Kerby GR, Ruth WE. Treatment of allergic aspergillosis with triamcinolone acetonide aerosol. Chest. 1977; 71(6):782 - 784.
    94. Hiller C, Mazumder M, Wilson D. Aerodynamic Size Distribution of Commercially Available Metered-Dose Bronchodilator Preparations. 1977; 400.
    95. Murphy E, Bone R, Hiller C, Diederich D, Ruth W. Red cell oxygen transport in obstructive pulmonary disease. 1976; 436-437.
    96. Hiller C, Bone R, Diederich D, Ruth W. The red blood cell in acute respiratory failure. 1975; 922.
    97. Goheen J, Gwin E, Hiller C, Henry J, Lampton L, Kerby G, Ruth W. Biopsy of lung nodules and infiltrates beyond visual range of bronchofiberscope. 1975; 690.
    98. Wilson FJ, Jr, Hiller F, Wilson JD, Bone RC. Deposition of ultra-small aerosols in the human respiratory tract.
    99. McGraw DW, Jacobi SE, Hiller F, Cornett LE. CIS - Acting Regulatory Elements in the Distal 5'-Flanking Region of the Rat ß2-Adrenergic Receptor Gene.
    100. Hammersley JR, Olson DE, Hiller F, (1990). Localization of aerosol deposition in mid-lung regions appears heavily influenced by secondary velocity patterns.
    101. McCusker K, Hiller F, Wilson D, Mazumder M, Bone R. Characterization of sidestream smoke from low tar cigarettes.
    102. Hartman P, Scrima L, Steadman D, Hiller F. The effects of alcohol on snoring induced hypoxic events in males during the first 3 hours of sleep.
    103. Anderson PJ, Eddlemon P, Gann LP, Hiller F. Efficacy of albuterol inhaled in helium-oxygen (Heliox) gas by asthmatic subjects.
    104. Scrima L, Hartman PG, Thomas EE, Hiller F. Sleep disordered breathing in obese and very obese 30-49 year old males: Effects of 3 alcohol doses.
    105. Paynter DE, Hiller F, Cornett LE, Norris JS, Popovich KJ. Beta-adrenergic densensitization in airway smooth muscle.
    106. Anderson PJ, Wilson FJ, Hiller FC, Bone RC. Effect of respiratory pattern on deposition of ultrafine aerosols in the human respiratory tract.
    107. Hiller F, Mazumder MK, Wilson FJ, Jr., Bone RC. Aerodynamic size distribution of therapeutic aerosols.
    108. Scrima L, Wetmore S, Hiller F. Surgical success indices of obstructive sleep apnea (OSA).
    109. Hardy K, Gann LP, Tennal KB, Hiller F, Anderson PJ. Comparison of aerosol bolus behavior and spirometry during bronchoprovocation.
    110. Hiller F, McCusker KT, Wilson JD, Mazumder MK, Bone RC. Physical properties of marijuana smoke.
    111. Hammersley JR, Snyder B, Hiller F. Secondary airflow patterns in models of the mid-lung region suggest convective disruption of inspiratory airflow by serial bifurcations.
    112. Hiller F, Razmi S, Zhou X, Breen P, Gann L, Compadre C, Anderson PJ. Pharmacokinetics of albuterol inhaled from metered dose in haler and nebulizer by asmathic subjects.
    113. Anderson PJ, Zhou X, Breen P, Gann L, Compadre C, Hiller F. Effect of a holding chamber on pharmacokinetics of inhaled albuterol in normal subjects.
    114. Balk RA, Bone RC, Hiller FC, Wilson FJ, Jr. Delayed methylprednisolone improves survival in murine endotoxin shock.
    115. Wetmore S, Scrima L, Hiller F. Epistaxis and sleep apnea.
    116. Anderson PJ, Wilson FJ, Hiller F, Bone RC, Lau I. Effect of respiratory pattern on deposition of ultrafine aerosols in the human respiratory tract.
    117. MacGregor TR, Gann LP, Hiller F, Hatch F, Boxenbaum HG. Human Lung absorption of metaproterenol.
    118. Scrima L, Stedman D, Thomas G, Johnson F, Hiller F. Arousal after alcohol ingestion in asymptomatic nocturnal myoclonus subjects.
    119. Bone R, Potter M, Wilson F, Hiller C, Kendall J. Endorphins in endotoxin shock.
    120. Beaton JN, Hiller F, Bone RC, Wilson FJ, Jr, Cragor EJ, Jr. Absorption of amiloride from an isolated perfused rat lung.
    121. Scrima L, Hartman PG, Thomas EE, Hiller F. Effect of gamma-hydroxybutyrate (GHB) on nocturnal myoclonus and respiration during sleep in narcolepsy patients.
    122. Anderson PJ, Wilson JD, Hiller F. Respiratory tract deposition of ultrafine particles in subjects with obstructive and restrictive lung disease.
    123. Gann LP, Olsen KM, Thompson LR, Ackerman BH, Pappas AA, Hiller F, 1991. Bioavailability of rifampin following rectal administration.
    124. Anderson PJ, Hardy K, Gann LP, Cole R, Hiller F. Aerosol bolus behavior: sensitivity to and specificity for small airway narrowing.
    125. McGraw DW, Chai SE, Hiller F, Cornett LE. Mechanisms underlying dexamethasone induction of the ß2-Adrenergic receptor in a human lung cell line.
    126. Popovich KJ, Hiller F, Cornett LE, Norris JS. (-)-Isoproterenol responsive adenylate cyclase in porcine trachealis muscle.
    127. Scrima L, Wetmore S, Lucas E, Hiller F. Indices to evaluate success of surgical correction of obstructive sleep apnea. Sleep Res Vol 14 (In Press).
    128. Hiller F, Cornett LE, Jacobi SE, Jones S, Anderson PJ. Aerosol dilevery of recombinant E2-adrenergic recpetor gene to porcine airways: description of viral vecor preparation and delivery.
    129. Scrima L, Hartman PG, Hiller F. Effects of 3 alcohol doses and age on breathing during sleep in 30-68 year old male snorers.
    130. Popovich KJ, Cornett LE, Norris JS, Hiller F, Bone RC. Indentification of a B2-adrenergic receptor in a cell membrane preparation from a porcine trachealis muscle.
    131. Hiller F, Razmi S, Zhou X, Breen P, Gann L, Campadre C, Anderson PJ. Pharmacokinetics of inaled albuterol in asthmatic subjects.
    132. Olsen KM, Gann LP, Anderson PJ, Marx MA, Ackerman BH, Hiller F. Effect of histamine-2 receptor antagonists on nicotine clearance in smokers.
    133. Herrmann DR, Olsen KM, Hiller F. Nicotine absorption following pulmonary instillation.
    134. Lau IKT, Hiller F, Mazumder MK, Wilson JD. The stability of BES aerosol generated by condensation methods.
    135. Scrima L, Hartman PG, Cardin R, Thomas EE, Hiller F. Normative data for respiration variables in 30-49 year old non-obese males.
    136. Paynter DE, Uthman EO, Hiller F. Cough fracture simulating neoplasm in a man with polycythemia.
    137. Anderson PJ, Zhou X, Breen P, Gann LP, Logsdon TW, Compadre C, Hiller F. Pulmonary absorption of inhaled albuterol.
    138. Anderson PJ, Gann LP, Walls RC, Tennal KB, Hiller F. Utility of aerosol bolus behavior as a diagnostic index of asthma during bronchoprovocation.
    139. Renninger R, Hiller F, Bone R. Predicted lung deposition of hygroscopic particles.
    140. Cao W, McGraw DW, Lee TT, Dicker-Brown A, Hiller F, Cornette LE, Jones SM. Expression of funcutional E2-adrenergic receptors in a rat airway epithelial cell line (SPOC1) and cell density-dependent induction by gucocorticoids.
    141. Balk RA, Tryka AF, Bone RC, Mazurek J, Holst L, Hiller F. The effect of ibuprofen on endotoxin induced injury in sheep.
    142. Johnson F, Scrima L, Thomas E, Stedman D, Hiller F. Calibrated snoring polysomnogram system.
    143. Scrima L, Hartman PG, Johnson F, Steadman D, Hiller F. Alcohol increases snoring in men ages 30-50.
    144. Scrima L, Hartman PG, Johnson FH, Hiller F. Effects of gamma-hydroxybutyrate (GHB) on sleep stages in narcolepsy patients: Results of a double-blind study.
    145. Cornett LE, Hiller F, Jacobi SE, Cao W, McGraw DW. Identification of a glucocorticoid response element in the rat E2-adrenegic receptor gene.
    146. Balk RA, Jacobs ER, Bone RC, Hiller FC, Wilson FJ, Jr. The effects of steroids and thromboxane synthetase inhibitors on endotoxin shock.
    147. Thomas E, Scrima L, Hiller F. Brief nasal CPAP trial immediately following diagnostic polysomnogram (PSG): A test of feasibility for all night CPAP-PSG and patient tolerance.
    148. Anderson PJ, Gann LP, Walls RC, Tennel KB, Hiller F. Using Aerosol Bolus Behavior to Diagnose Asthmatics with Normal Spirometry.
    149. Hammersley JR, Anderson P, Hiller FC. 1991. Particulate deposition in mid-lung regions is influenced by local airway geometry.
    150. Hermann DR, Gann LP, Olsen KM, Hiller F. (1990) Pulmonary absorption of instilled nicotine.
    151. Cao W, Hiller F, Jacobi SE, Cornette LE, Jones SM. Glucocorticoid regulation of E2-adrenergic receptor gene expression in rat airway epithelial cells.
    152. Hiller F, Mazumder M, Wilson D, Bone R. Quantitative simultaneous measurement of deposition of aerosols of different sizes in the human.
    153. Anderson PJ, Hiller F. Particle size distribution of mainstream tobacco and marijuana smoke using the electrical aerosol analyzer.
    154. Scrima L, Hartman PG, Nowack W, Johnson FH, Hiller F. Long-tern effectiveness of gamma-hydroxybutyrate in treating cataplexy and sleepiness in narcolepsy patients.
    155. Nolan D, Rendon A, Hiller F. The frequency and consequences of an unclear diagnosis (UD) upon admission to a Medical Intensive Care Unit (MICU).
    156. McGraw DW, Chai SE, Hiller F, Cornett LE. B2 - adrenergic receptor and in RNA levels in rat lungs following invivo administration of glucocorticoids.
    157. Scrima L, Hartman PG, Thomas EE, Hiller F. Sleep disordered breathing in non-obese 30-49 year old snorers vs. non-snorers: Effects of 3 alcohol doses.
    158. Hiller F, McCusker K, Mazumder M, Wilson D, Bone R. Quantitative deposition of sidestream smoke in the human respiratory tract.
    159. Jacobs E, Bone R, Wilson F, Hiller C. Combined use of methylprednisolone and naloxone in endotoxemia.
    160. Erbland ML, Olsen KM, Gann LP, Patrick C, Hiller F. (1990) Comparison of plasma nicotine concentrations obtained from a new cigarette device and conventional cigarettes.
    161. Burch SG, Erbland ML, Gann LP, Hiller F. Effect of pH on nicotine absorption and side effects produced by aerosolized nicotine.
    162. McCusker K, Hiller F, Mazumder M, Bone R. Dynamic growth of cigarette smoke particles.
    163. Dorsey DR, Tabor DR, Hiller F, Jacobs RF. Pulmonary macrophage function in canine endotoxin-induced lung injury.
    164. Anderson PJ, Zhou X, Breen P, Gann LP, Logsdon TW, Compadre C, Hiller F. Effect of gender on lung uptake of inhaled albuterol.
    165. Scrima L, Hartman PG, Johnson FH, Thomas EE, Hiller F. Effect of gamma-hydroxybutyrate (GHB) on narcolepsy-cataplexy symptoms and MSLT results in male and female patients.
    166. Anderson PJ, Zhou X, Breen P, Gann L, Compadre C, Hiller F. Effectt of a holding chamber on pharmacokinetics of inhaled albuterol in normal subjects.
    Same Department Expand Description
    Search Department